The effect of Pygeum Africanum on fibroblast growth factor (FGF) and transforming growth factor beta (TGFβ1/LAP) expression in animal model

Acta Microbiologica et Immunologica Hungarica

Volumn 48, Issue 1, 2001, Pages 1-9

  Szolnoki, Erzsébet ^a   Reichart, E ^b   Marchal, Sophie ^c   Szegedi, Gy ^a  

^a UNIVERSITY OF DEBRECEN   (Hungary)

^b INSERM   (France)

^c Centre A Vautrin   (France)

Author keywords

Anti inflammatory drug; Fibroblast growth factor; Transforming growth factor beta

Indexed keywords

ANIMALIA; PRUNUS AFRICANA; PYGEUM;

BLEOMYCIN; FATTY ALCOHOL; FIBROBLAST GROWTH FACTOR; NONSTEROID ANTIINFLAMMATORY AGENT; PLANT EXTRACT; PYGEUM AFRICANUM EXTRACT; TRANSFORMING GROWTH FACTOR BETA;

ANIMAL; ARTICLE; CHEMICALLY INDUCED DISORDER; CYTOLOGY; DRUG EFFECT; LUNG ALVEOLUS MACROPHAGE; LUNG FIBROSIS; LUNG LAVAGE; MALE; METABOLISM; NEUTROPHIL; RAT; WISTAR RAT;

ANIMALS; ANTI-INFLAMMATORY AGENTS, NON-STEROIDAL; BLEOMYCIN; BRONCHOALVEOLAR LAVAGE FLUID; FATTY ALCOHOLS; FIBROBLAST GROWTH FACTORS; MACROPHAGES, ALVEOLAR; MALE; NEUTROPHILS; PLANT EXTRACTS; PULMONARY FIBROSIS; RATS; RATS, WISTAR; TRANSFORMING GROWTH FACTOR BETA;

EID: 0035220901     PISSN: 12178950     EISSN: None     Source Type: Journal    
DOI: 10.1556/AMicr.48.2001.1.1     Document Type: Article

References (15)

1. Barlet, A., Albrecht, J., Aubert, A.: Efficacy of Pygeum africanum extract in the treatment of micturitional disorders due to benign prostatic hyperplasia. Evaluation of objective and subjective parameters. Wiener Klinische Wochenschrift 232 (1990).
2. Donkervouri, T., Sterling, A., van Ness, J., Donker, P.J.: A clinical and urodynamic study of Tadenan, in the treatment of benign prostatic hypertrophy. Eur Urol 3, 218 (1977).
3. Thrall, RS., McCormick, J.R., Jack, B.A., McReynolds, R.A., Ward, P.A.: Bleomycin-induced pulmonary fibrosis in the rat. Am J Pathology 117 (1979).
4. Thrall, RS., Phan, S.H., MCCormick, J.R., Ward, P.A.: The development of bleomycin-induced pulmonary fibrosis in neutrophil-depleted and complement-depleted rats. Am J Pathology 76 (1981).
5. Bowden, D.H.: Unraveling pulmonary fibrosis: the bleomycin model [editorial]. Lab Invest 50, 487 (1984).
6. Giri, S.N., Hyde, D.M., Braun, R.K., Gaarde, W., Harper, J.R., Pierschbacher, M.D.: Antifibrotic effect of decorin in a bleomycin hamster model of lung fibrosis. Biochemical Pharmacology 54, 1205 (1997).
7. Everson, M.P., Chandler, D.B.: Changes in distribution, morphology, and tumor necrosis factor-alpha secretion of alveolar macrophage subpopulations during the development of bleomycin-induced pulmonary fibrosis. Am J Pathol 140, 503 (1992).
8. Thrall, R.S., Barton, R.W.: A comparison of lymphocyte populations in lung tissue and in bronchoalveolar lavage fluid of rats at various times during the development of bleomycin-induced pulmonary fibrosis. Am Rev Respir Dis 129, 279 (1984).
9. Phan, S.H., Kunkel, S.L.: Lung cytokine production in bleomycin-induced pulmonary fibrosis. Exp Lung Res 18, 29 (1982).
10. Giri, S.N., Hyde, D.M.: Ameliorating effect of an interferon inducer polyinosinic-polycytidylic acid on bleomycin-induced lung fibrosis in hamsters. Morphologic and biochemical evidence. Am J Pathol 133, 525 (1988).
11. Giri, S.N., Hyde, D.M., Schiedt, M.J.: Effects of repeated administration of N-acetyl-L-cysteine on sulfhydryl levels of different tissues and bleomycin-induced lung fibrosis in hamsters. J Lab Clin Med 111, 715 (1988).
12. Grunze, M.F., Parkinson, D., Sulavik, S.B., Thrall, R.S.: Effect of corticosteroids on lung volume-pressure curves in bleomycin-induced lung injury in the rat. Exp Lung Res 14, 183 (1988).
13. Keane, M.P., Belperio, J.A., Moore, T.A., Moore, B.B., Arenberg, D.A., Smith, R.E., Burdick, M.D., Kunkel, S.L., Strieter, R.M.: Neutralization of the CXC chemokine, macrophage inflammatory protein-2, attenuates bleomycin-induced pulmonary fibrosis. J Immunol 162, 5511 (1999).
14. Nici, L. Santos, M.A., Kuhn, C., Calabresi, P.: Modulation of bleomycin-induced pulmonary toxicity in the hamster by the antioxidant amifostine. Cancer 83, 2008 (1998).
15. Wang, Q., Hollinger, M.A., Giri, S.N.: Attenuation of amiodarone-induced lung fibrosis and phospholipidosis in hamsters by taurine and/or niacin treatment. J Pharmacol Exp Ther 262, 127 (1992).